Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.640
+0.350 (27.13%)
At close: Oct 21, 2025, 4:00 PM EDT
1.610
-0.030 (-1.83%)
After-hours: Oct 21, 2025, 7:53 PM EDT

Prelude Therapeutics Revenue

Prelude Therapeutics had revenue of $7.00M in the twelve months ending June 30, 2025. In the year 2024, Prelude Therapeutics had annual revenue of $7.00M.

Revenue (ttm)
$7.00M
Revenue Growth
n/a
P/S Ratio
17.79
Revenue / Employee
$53,435
Employees
131
Market Cap
124.86M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.00M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

PRLD News

More News